Immunofuse Email Formats
Biotechnology Research • • 1-10 Employees
Key Contact at Immunofuse
Roger Swartz
Co-Founder
About Immunofuse
At Immunofuse we are focused on A New Immunization Modality against Type I Hypersensitivity, Respiratory Viruses, HIV, H. Pylori, Cancer , Ebola, Eosinphilic Esophagitis, Novel and Reinvigorated Antibody Programs, Cancer that enter through the mucosa. Our main focus is the episomal or genomic expression via gene therapy of Dimeric Immunoglobulin A1 (dIgA1) which, becomes secretory immunoglobulin A1 (SIgA1) as part of traversing the epithelium into the mucus. Our gene therapy can work for all including adults of older age and persons with underlying medical conditions because we bypass the adaptive immune system.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Immunofuse has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Immunofuse has never raised funding before.
United Kingdom
Switzerland
France
Frequently asked questions
4.8
40,000 users
